Fundamentals-based quality & risk · not a recommendation
Raw blend 41 capped to 40 by a red flag.
Raw blend 41 → capped to 40
Neogen Chemicals Ltd scores 40/100 (Caution) on the Orion Score — weak business quality (38), moderate growth (66) and poor balance-sheet safety (24). A fundamentals-based quality & risk score, not a buy/sell recommendation.
Risk checks
Forensic accounting
Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check
Technical / Momentum
Price Trend
88/100
Technical momentum companion — separate from the fundamentals-based Orion Score.
Unlock with Pro
Upgrade →Q4 FY2026
Revenue & Profit in ₹ Crores
| Quarter | Revenue | Net Profit | OPM | EPS |
|---|---|---|---|---|
| Q4 2026 | ₹246.56 | ₹11.39 | 14.7% | ₹4.32 |
| Q3 2026 | ₹220.02 | ₹3.69 | 11.4% | ₹1.40 |
| Q2 2026 | ₹208.66 | ₹3.37 | 10.8% | ₹1.28 |
| Q1 2026 | ₹186.73 | ₹10.26 | 13.8% | ₹3.89 |
| Q4 2025 | ₹202.82 | ₹2.41 | 14.6% | ₹0.91 |
Revenue & Profit in ₹ Crores (Yearly)
| Year | Revenue | Net Profit | EBITDA | OPM |
|---|---|---|---|---|
| FY 2026 | ₹861.96 | ₹28.75 | ₹143.71 | 12.7% |
| FY 2025 | ₹777.56 | ₹34.83 | ₹126.45 | 14.0% |
| FY 2024 | ₹670.83 | ₹35.65 | ₹113.42 | 13.0% |
| FY 2023 | ₹660.48 | ₹49.97 | ₹110.93 | 14.4% |
Top companies in the same sector by market cap
| Company | Mkt Cap | P/E | ROCE | ROE | D/E | OPM |
|---|---|---|---|---|---|---|
| NEOGEN ★ | ₹5,212 Cr | 175.45 | 6.40% | 3.58% | 1.71x | 14.73% |
| AETHER | ₹18,945 Cr | 86.46 | 11.68% | 9.38% | 0.19x | 21.06% |
| ATUL | ₹18,865 Cr | 27.80 | 10.56% | 11.53% | 0.03x | 17.07% |
| CHAMBLFERT | ₹17,268 Cr | 8.84 | 19.66% | 20.45% | 0.10x | 5.92% |
| ANURAS | ₹14,226 Cr | 81.35 | 8.65% | 5.76% | 0.41x | 18.15% |
| ACI | ₹6,850 Cr | 64.29 | 6.58% | 5.55% | 0.24x | 6.94% |
All values in ₹ Crores
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total Assets | ₹1,747.31 | ₹1,461.4 | ₹1,053.8 | ₹799.43 |
| Equity | ₹789.4 | ₹760.29 | ₹482.52 | ₹439.32 |
| Total Debt | ₹596.74 | ₹408.92 | ₹369.51 | ₹228.75 |
| Cash | ₹4.96 | ₹12.23 | ₹18.22 | ₹32.8 |
| Net Debt | ₹561.08 | ₹381.3 | ₹343.99 | ₹191.93 |
| Working Capital | ₹266.43 | ₹256.69 | ₹246.09 | ₹274.19 |
Q1 FY2027
Quarter-over-Quarter Trend
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Q1 FY2027 | 52.23% ↑ | 13.59% ↑ | 11.12% ↓ | 23.06% ↑ |
| Q3 FY2026 | 51.22% | 4.57% ↓ | 21.99% ↓ | 22.21% ↑ |
| Q2 FY2026 | 51.22% | 5.15% ↓ | 25.22% ↑ | 18.4% ↓ |
| Q1 FY2026 | 51.22% | 7.35% ↓ | 22.96% ↑ | 18.45% ↑ |
| Q4 FY2025 | 51.22% | 7.79% ↑ | 22.75% ↑ | 18.22% ↓ |
| Q3 FY2025 | 51.22% | 7.73% ↓ | 22.52% ↑ | 18.51% ↑ |
| Q2 FY2025 | 51.22% ↓ | 8.17% ↑ | 22.48% ↓ | 18.12% ↑ |
| Q1 FY2025 | 56.89% | 4.65% | 22.54% | 15.93% |
No recent corporate actions
24 mutual fund schemes
Ask: "Is Neogen Chemicals Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation
Analyse with OrionGet free stock analysis, market insights, and investment ideas delivered to your inbox.
No spam. Unsubscribe anytime.
Neogen Chemicals Ltd is listed on the NSE under the Chemicals sector, Specialty Chemicals industry. ISIN: INE136S01016. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.